Depression of C fibre-evoked spinal field potentials by the spinal δ opioid receptor is enhanced in the spinal nerve ligation model of neuropathic pain: Involvement of the μ-subtype

Neuropharmacology

Volumn 55, Issue 8, 2008, Pages 1376-1382

  Buesa, Itsaso ^a   Urrutia, Andrés ^a   Aira, Zigor ^a   Salgueiro, Monika ^a   Bilbao, Juan ^a   Mozas, Mercedes ^b   Aguilera, Luciano ^a   Zimmermann, Manfred ^c   Azkue, Jon Jatsu ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Hospital de San Eloy   (Spain)

^c Neuroscience and Pain Research Institute   (Germany)

Author keywords

Antinociception; Electrophysiology; Neuropathy; Nociception; Plasticity; Spinal cord

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN II [2 DEXTRO ALANINE]; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALTRINDOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; MALE; NERVE CELL PLASTICITY; NERVE FIBER C; NERVE LIGATION; NEUROMODULATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL NERVE;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; EVOKED POTENTIALS; MALE; NARCOTIC ANTAGONISTS; NERVE FIBERS, UNMYELINATED; NEURALGIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SOMATOSTATIN; SPINAL CORD;

EID: 56249098991     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.08.029     Document Type: Article

References (55)

1. Abbadie C., Pasternak G.W., and Aicher S.A. Presynaptic localization of the carboxy-terminus epitopes of the mu opioid receptor splice variants MOR-1C and MOR-1D in the superficial laminae of the rat spinal cord. Neuroscience 106 (2001) 833-842
2. Aimone L.D., and Yaksh T.L. Opioid modulation of capsaicin-evoked release of substance P from rat spinal cord in vivo. Peptides 10 (1989) 1127-1131
3. Arnér S., and Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33 (1988) 11-23
4. Arvidsson U., Riedl M., Chakrabarti S., Lee J.H., Nakano A.H., Dado R.J., Loh H.H., Law P.Y., Wessendorf M.W., and Elde R. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15 (1995) 3328-3341
5. Attal N., Kayser V., Jazat F., and Guilbaud G. Behavioral evidence for a bidirectional effect of systemic naloxone in a model of experimental neuropathy in the rat. Brain Res. 494 (1989) 276-284
6. Azkue J.J., Liu X.G., Zimmermann M., and Sandkühler J. Induction of long-term potentiation of C fibre-evoked spinal field potentials requires recruitment of group I, but not group II/III metabotropic glutamate receptors. Pain 106 (2003) 373-379
7. Back S.K., Lee J., Hong S.K., and Na H.S. Loss of spinal mu-opioid receptor is associated with mechanical allodynia in a rat model of peripheral neuropathy. Pain 123 (2006) 117-126
8. Beck H., Schrock H., and Sandkühler J. Controlled superfusion of the rat spinal cord for studying non-synaptic transmission: an autoradiographic analysis. J. Neurosci. Methods 58 (1995) 193-202
9. Berenbaum M.C. What is synergy?. Pharmacol. Rev. 41 (1989) 93-141
10. Besse D., Lombard M.C., Zajac J.M., Roques B.P., and Besson J.M. Pre- and postsynaptic distribution of mu, delta and kappa opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res. 521 (1990) 15-22
11. Besse D., Lombard M.C., Perrot S., and Besson J.M. Regulation of opioid binding sites in the superficial dorsal horn of the rat spinal cord following loose ligation of the sciatic nerve: comparison with sciatic nerve section and lumbar dorsal rhizotomy. Neuroscience 50 (1992) 921-933
12. Buesa I., Ortiz V., Aguilera L., Torre F., Zimmermann M., and Azkue J.J. Disinhibition of spinal responses to primary afferent input by antagonism at GABA receptors in urethane-anaesthetised rats is dependent on NMDA and metabotropic glutamate receptors. Neuropharmacology 50 (2006) 585-594
13. Buesa I., Urrutia A., Bilbao J., Aguilera L., Zimmermann M., and Azkue J.J. Non-linear morphine-induced depression of spinal excitation following long-term potentiation of C fibre-evoked spinal field potentials. Eur. J. Pain 12 (2008) 814-817
14. B receptor activity. Eur. J. Pain 12 (2008) 677-685
15. Cadden S.W. The ability of inhibitory controls to 'switch-off' activity in dorsal horn convergent neurones in the rat. Brain Res. 628 (1993) 65-71
16. Cahill C.M., White T.D., and Sawynok J. Synergy between mu/delta-opioid receptors mediates adenosine release from spinal cord synaptosomes. Eur. J. Pharmacol. 298 (1996) 45-49
17. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53 (1994) 55-63
18. Cheng P.Y., Liu-Chen L.Y., and Pickel V.M. Dual ultrastructural immunocytochemical labeling of mu and delta opioid receptors in the superficial layers of the rat cervical spinal cord. Brain Res. 778 (1997) 367-380
19. Dickenson A.H., and Suzuki R. Opioids in neuropathic pain: clues from animal studies. Eur. J. Pain 9 (2005) 113-116
20. Egan T.M., and North R.A. Both mu and delta opiate receptors exist on the same neuron. Science 214 (1981) 923-924
21. Fields H.L., Emson P.C., Leigh B.K., Gilbert R.F., and Iversen L.L. Multiple opiate receptor sites on primary afferent fibres. Nature 284 (1980) 351-353
22. Gendron L., Pintar J.E., and Chavkin C. Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia. Neuroscience 150 (2007) 807-817
23. Gomes I., Jordan B.A., Gupta A., Trapaidze N., Nagy V., and Devi L.A. Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J. Neurosci. 20 (2000) 1-5
24. 125I] FK-33-824-labelled mu opioid receptors in the spinal cord of normal and deafferented rats. Neuroscience 43 (1991) 197-209
25. Hao J.X., Yu W., Wiesenfeld-Hallin Z., and Xu X.J. Treatment of chronic allodynia in spinally injured rats: effects of intrathecal selective opioid receptor agonists. Pain 75 (1998) 209-217
26. Holdridge S.V., and Cahill C.M. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Eur. J. Pain 11 (2007) 685-693
27. Hylden J.L., Nahin R.L., Traub R.J., and Dubner R. Effects of spinal kappa-opioid receptor agonists on the responsiveness of nociceptive superficial dorsal horn neurons. Pain 44 (1991) 187-193
28. Kayser V., and Guilbaud G. Physiological relevance and time course of a tonic endogenous opioid modulation of nociceptive messages, based on the effects of naloxone in a rat model of localized hyperalgesic inflammation. Brain Res. 567 (1990) 197-203
29. Keck B.J., Stafinsky J.L., Uram M., and Crisp T. A lack of supersensitivity to opioid receptor agonists following chronic spinal opioid receptor antagonist administration in the rat. Gen. Pharmacol. 26 (1995) 161-168
30. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
31. Kohno T., Ji R.R., Ito N., Allchorne A.J., Befort K., Karchewski L.A., and Woolf C.J. Peripheral axonal injury results in reduced mu opioid receptor pre- and post-synaptic action in the spinal cord. Pain 117 (2005) 77-87
32. Kovelowski C.J., Bian D., Hruby V.J., Lai J., Ossipov M.H., and Porreca F. Selective opioid delta agonists elicit antinociceptive supraspinal/spinal synergy in the rat. Brain Res. 843 (1999) 12-17
33. Le Bars D., Guilbaud G., Jurna I., and Besson J.M. Differential effects of morphine on responses of dorsal horn lamina V type cells elicited by A and C fibre stimulation in the spinal cat. Brain Res. 115 (1976) 518-524
34. Levine J.D., Gordon N.C., Jones R.T., and Fields H.L. The narcotic antagonist naloxone enhances clinical pain. Nature 272 (1977) 826-827
35. Malmberg A.B., and Yaksh T.L. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB). J. Pharmacol. Exp. Ther. 263 (1992) 264-275
36. Mansikka H., Zhao C., Sheth R.N., Sora I., Uhl G.R., and Raja S.N. Nerve injury induces a tonic bilateral mu-opioid receptor-mediated inhibitory effect on mechanical allodynia in mice. Anesthesiology 100 (2004) 912-921
37. Mansour A., Burke S., Pavlic R.J., Akil H., and Watson S.J. Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary. Neuroscience 71 (1996) 671-690
38. Marker C.L., Lujan R., Loh H.H., and Wickman K. Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids. J. Neurosci. 25 (2005) 3551-3559
39. Mika J., Przewłocki R., and Przewłocka B. The role of delta-opioid receptor subtypes in neuropathic pain. Eur. J. Pharmacol. 415 (2001) 31-37
40. Mizoguchi H., Narita M., Nagase H., and Tseng L.F. Antisense oligodeoxynucleotide to a delta-opioid receptor blocks the antinociception induced by cold water swimming. Regul. Pept. 59 (1995) 255-259
41. Molander C., Xu Q., and Grant G. The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. J. Comp. Neurol. 230 (1984) 133-141
42. Nadal X., Baños J.E., Kieffer B.L., and Maldonado R. Neuropathic pain is enhanced in delta-opioid receptor knockout mice. Eur. J. Neurosci. 23 (2006) 830-834
43. Narita M., Kuzumaki N., Suzuki M., Narita M., Oe K., Yamazaki M., Yajima Y., and Suzuki T. Increased phosphorylated-mu-opioid receptor immunoreactivity in the mouse spinal cord following sciatic nerve ligation. Neurosci. Lett. 354 (2004) 148-152
44. Ossipov M.H., Lopez Y., Nichols M.L., Bian D., and Porreca F. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury. Neurosci. Lett. 199 (1995) 83-86
45. Portenoy R.K., Foley K.M., and Inturrisi C.E. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 43 (1990) 273-286
46. Reche I., Fuentes J.A., and Ruiz-Gayo M. A role for central cannabinoid and opioid systems in peripheral delta 9-tetrahydrocannabinol-induced analgesia in mice. Eur. J. Pharmacol. 301 (1996) 75-81
47. Stevens C.W., Kajander K.C., Bennett G.J., and Seybold V.S. Bilateral and differential changes in spinal mu, delta and kappa opioid binding in rats with a painful, unilateral neuropathy. Pain 46 (1991) 315-326
48. Stewart P.E., and Hammond D.L. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin. J. Pharmacol. Exp. Ther. 266 (1993) 820-828
49. Stone L.S., Vulchanova L., Riedl M.S., Williams F.G., Wilcox G.L., and Elde R. Effects of peripheral nerve injury on delta opioid receptor (DOR) immunoreactivity in the rat spinal cord. Neurosci. Lett. 361 (2004) 208-211
50. Sullivan A.F., and Dickenson A.H. Electrophysiologic studies on the spinal antinociceptive action of kappa opioid agonists in the adult and 21-day-old rat. J. Pharmacol. Exp. Ther. 256 (1991) 1119-1125
51. Suzuki R., Morcuende S., Webber M., Hunt S.P., and Dickenson A.H. Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat. Neurosci. 5 (2002) 1319-1326
52. Tambeli C.H., Quang P., Levine J.D., and Gear R.W. Contribution of spinal inhibitory receptors in heterosegmental antinociception induced by noxious stimulation. Eur. J. Neurosci. 18 (2003) 2999-3006
53. Traynor J., and Elliot J. Delta-opioid receptor subtypes and cross talk with mu-receptors. Trends Pharmacol. Sci. 14 (1993) 84-86
54. Welch S.P., and Stevens D.L. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice. J. Pharmacol. Exp. Ther. 262 (1992) 10-18
55. Zhang X., Bao L., Arvidsson U., Elde R., and Hökfelt T. Localization and regulation of the delta-opioid receptor in dorsal root ganglia and spinal cord of the rat and monkey: evidence for association with the membrane of large dense-core vesicles. Neuroscience 82 (1998) 1225-1242